OBJECTIVE: As chronic pelvic pain can be a challenge for both patients and their physicians, we present our approach to the management of pelvic floor myofascial spasm and how/when to perform pelvic floor trigger point and botulinum A injections. DESCRIPTION: The video summarizes therapeutic options for pelvic floor myofascial spasm and details the procedure used for officebased pelvic floor trigger point injections and botulinum A injections in the operating room. CONCLUSION: In cases of myofascial pain syndrome, multi-modal therapy including physical therapy, medical management, and trigger point injections is often required.
OBJECTIVE: Endometrioma are benign, estrogen dependent ovarian cysts that are found in 17-44% of women with advanced endometriosis during reproductive years of life. Very few cases have been have been reported where the endometrioma was found outside the ovary. A recent publication by Trehan described the laparoscopic management of endometrioma of the broad ligament. Only two other cases of endometrioma have been described outside the ovaries in the literature. In this report we describe the laparoscopic management of what we believe is the first reported case of myometrium endometioma after failure of transvaginal ultrasound to identify the precise location of the cyst. DESCRIPTION: Patient is a 30-year-old white female G0 with history of endometriosis. After imaging workup, a 32 Â 24 mm left adnexal mass was noted on transvaginal ultrasound. The mass appeared to be cystic with and echogenic, increasing the suspicion for a dermoid cyst. Patient opted to undergo diagnostic laparoscopy where the rare finding of myometrium endometrioma was discovered. The cyst was excised, drained and the cyst wall dissected. The cavity gap was repaired using a 3-layer closure. CONCLUSION: This report suggests that endometrioma can be present within the myometrium and provides further evidence suggesting the etiology of endometriomas can be explained by methods other than retrograde menstruation.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Osama A. Zaghmout: Nothing to disclose; Omar Abuzeid: Nothing to disclose; John Hebert: Nothing to disclose; Mostafa Abuzeid: Nothing to disclose. OBJECTIVE: This video demonstrates a novel vaginal surgical technique, applying barbed suture technology to anterior colporrhaphy for fascial plication in order to reduce operative time and to potentially improve tissue approximation. DESCRIPTION: The crucial plication step during colporrhaphy provides the strength of pelvic floor reinforcement. This is traditionally performed using a series of interrupted sutures. Barbed suture is a relatively new addition to surgical suture technology, where the notched surface prohibits slippage of the suture through tissue and evenly distributes tissue forces. The design of these sutures also avoids the tying of knots, which reduces operative time while eliminating the disadvantages of knots including uneven tissue strength distribution, inflammatory reaction from knot volume and ischemia from excessive tension, all of which may lead to disrupted tissue healing. Barbed suture has been shown to be superior to traditional suture tying in distributing strength along the length of a wound, securing hemostasis, and preventing wound leakage at the approximation site. Wound closure times have been shown to be consistently shorter with barbed suture when compared to traditional methods. This suture technology has been successfully used in other gynecological surgeries, including vaginal cuff closure in laparoscopic total hysterectomy, uterine defect closure in laparoscopic myomectomy, and peritoneal closure in laparoscopic sacrocolpopexy. In this surgical approach, 3-0 V-Loc TM 180 delayed absorbable uni-directional barbed self-anchoring suture (Coviden, Mansfield, MA, USA) was used in anterior colporrhaphy for plication of the pubovesical fascia in a single running Cushing stitch, with 2-0 polyglactin suture used for vaginal mucosal closure. CONCLUSION: Barbed suture has multiple advantages in improving operative time and tissue approximation, making it an effective and efficient addition to vaginal reconstructive surgery.
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